Run the checker

State filing guide

CLIA waiver application and requirements in Connecticut.

Ask about my application — no payment today

Connecticut's waived-only clinical-laboratory license exemption is RCSA 19a-36-D21(a)(4)(D); CMS-116 applications go through the state CLIA program.

Sources checked 2026-10-31 · next source check due 2026-11-30

Federal application procedure

These findings describe the linked sources. They do not establish that your facility qualifies for an exemption or that its application is ready. Facility type, ownership, personnel, locations and exact test systems can change the requirements.

Have your Connecticut CLIA waiver application prepared for you — US$195

We check each test you plan to run, prepare your Connecticut CMS-116 ready to sign, and give you signature and filing instructions. If our check shows that you do not need a certificate, or we cannot take your case, we refund the US$195 in full. Leave your email and we will send you the details and the payment link.

Request for Connecticut price and payment link

Business details only. Do not enter patient information or government identifiers.

What the official sources say

  • Connecticut DPH and the CMS state-agency directory list DPH.FLISLab@ct.gov and 860-509-7400. Confirm the accepted initial-application channel before filing.
  • The CMS directory lists Connecticut Department of Public Health, P.O. Box 340308, 410 Capitol Avenue, MS#12 FLIS, Hartford CT 06134-0308; fax 860-706-5805. These are agency contacts; confirm initial-filing acceptance before using mail or fax.
  • The consolidated RCSA, amended October 8, 2026, places the waived-only clinical-laboratory license exemption at D21(a)(4)(D), formerly D22(b)(4).
  • RCSA D23 addresses specimen collection facilities. RCSA F2 and CGS 19a-490(t) address blood-collection facilities, with the statute defining blood collected for administration to a human. Ordinary diagnostic collection does not by itself establish that classification.
  • Form CMS-116 is revision 04/2026, OMB 0938-0581, with expiration April 30, 2029. Confirm the accepted edition and signature format before filing.
  • We confirm any case-specific state forms or EUA attestation requirements with the state program before filing.

Fees and timing

Federal Certificate of Waiver: $248 per two-year certificate, paid by the client through Pay.gov after the emailed CMS fee notice; no payment with CMS-116 and no paper checks since March 1, 2026. The exempt waived-only laboratory has no state clinical-laboratory license application fee; CGS 19a-565(f) $200 applies only to a separately required state license. No published Connecticut initial-processing or issuance SLA was verified. Government fees are separate from preparation-service fees.

Check my test menu

What still needs confirmation for your facility

  1. 1Confirm that the complete menu is waived-only and whether the site also operates as a blood-collection facility.
  2. 2Confirm whether the facility qualifies for the D21(a)(4)(D) exemption and whether D23 or F2/19a-490(t) collection-facility provisions apply.
  3. 3Confirm the accepted CMS-116 edition, signed-attachment format and initial-filing channel, and whether any current case-specific EUA attestation applies.

Frequently asked questions

What filing route does the cited Connecticut guidance describe?

Connecticut's waived-only clinical-laboratory license exemption is RCSA 19a-36-D21(a)(4)(D); CMS-116 applications go through the state CLIA program.

Which requirements are named in the cited Connecticut materials?

Connecticut DPH and the CMS state-agency directory list DPH.FLISLab@ct.gov and 860-509-7400. Confirm the accepted initial-application channel before filing. The CMS directory lists Connecticut Department of Public Health, P.O. Box 340308, 410 Capitol Avenue, MS#12 FLIS, Hartford CT 06134-0308; fax 860-706-5805. These are agency contacts; confirm initial-filing acceptance before using mail or fax. The consolidated RCSA, amended October 8, 2026, places the waived-only clinical-laboratory license exemption at D21(a)(4)(D), formerly D22(b)(4). RCSA D23 addresses specimen collection facilities. RCSA F2 and CGS 19a-490(t) address blood-collection facilities, with the statute defining blood collected for administration to a human. Ordinary diagnostic collection does not by itself establish that classification. Form CMS-116 is revision 04/2026, OMB 0938-0581, with expiration April 30, 2029. Confirm the accepted edition and signature format before filing. We confirm any case-specific state forms or EUA attestation requirements with the state program before filing.

What do the sources establish about fees and timing in Connecticut?

Federal Certificate of Waiver: $248 per two-year certificate, paid by the client through Pay.gov after the emailed CMS fee notice; no payment with CMS-116 and no paper checks since March 1, 2026. The exempt waived-only laboratory has no state clinical-laboratory license application fee; CGS 19a-565(f) $200 applies only to a separately required state license. No published Connecticut initial-processing or issuance SLA was verified. Government fees are separate from preparation-service fees.

Does this page confirm CLIA approval or legal compliance in Connecticut?

No. This is an educational prep checklist. It does not confirm approval, legal compliance, or waived status for any specific device. Verify every requirement with CMS, the FDA, and your state agency before testing.

Other jurisdictions

Each jurisdiction publishes its own terminology, forms, channel, signatures, and fees.

All 52jurisdictions →

Need help with your Connecticut CLIA route?

Tell us where your clinic operates and what you need to prepare or change. You can ask before you know your exact test system. We review the next facts needed before proposing any paid scope.

Request a scope inquiry — no payment today

Business inquiries only. Do not send patient information, test results, dates of birth, government identifiers, credential numbers, or documents.

Initial business inquiry

From test research to your Connecticut application

An analyte label does not confirm a device. The exact test system and the clinic’s state route need separate review before a filing scope or price can be confirmed.